Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | 0% | $ 341.42M | $ 0 |
3/31/2025 | -21% | $ 156.92M | $ 32.95M |
12/31/2024 | -35.52% | $ 201.79M | $ 71.68M |
9/30/2024 | 0% | $ 207.44M | $ 0 |
6/30/2024 | 0% | $ 163.58M | $ 0 |
12/31/2023 | 0% | $ 0 | $ 201.96M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for INHIBRX BIOSCIENCES INC is calculated as follows: (-1 * CF - Equity [ $ 201.96M ]) / Market Cap [ $ 0 ]
(=) Buyback Yield [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |